HKAPI Regulatory Training Workshop Series – Seminar 1
Virtual MeetingSeminar 1:
1. Highlights of Regulatory Trends in 2022
2. Counterfeits and Parallel imports in Hong Kong
Menu
Seminar 1:
1. Highlights of Regulatory Trends in 2022
2. Counterfeits and Parallel imports in Hong Kong
Seminar 2 - New product registration and Good reliance pathway
Date: 4 March 2022 (Fri)
Time: 2:00 pm - 4:30 pm
Seminar 3 - CORP & e-labelling
Date: 11 March 2022 (Fri)
Time: 2:00 pm - 4:30 pm
Seminar 4 - ATP new product registration & clinical trial applications and Real World Evidence
Date: 18 March 2022 (Fri)
Time: 4:00 pm- 6:00pm
Seminar 5 - Medical Devices & Private Healthcare Facilities Ordinance
Date: 25 March 2022 (Fri)
Time: 2:00 pm - 4:30 pm
The Regulatory Working Group will kick off an all-year-long survey on Regulatory Intelligence to learn from members the latest practices of local & overseas regulators that may bring systemic impact on the local regulatory requirements and keep members abreast of these updates via regular forums. Before kicking off the survey, the Working Group organizes a […]
In this seminar, representatives from Linklaters will cover key enforcement trends in the past year, as well as provide you with insights into proceedings in the Competition Tribunal. We will also discuss how this is relevant to the pharmaceutical industry in Hong Kong and practical tips to ensure full compliance with competition law.
To facilitate good submission practices of the industry, the HKAPI Regulatory Working Group will organize a 2-day education workshop on 24 Nov and 5 Dec. We will have overseas speakers and local regulators from the Drug Office to share insights on NCE/CORP applications, relevant regulatory updates, overseas experiences of primary review and ePI implementation, followed […]
To facilitate good submission practices of the industry, the HKAPI Regulatory Working Group will organize a 2-day education workshop on 24 Nov and 5 Dec. We will have overseas speakers and local regulators from the Drug Office to share insights on NCE/CORP applications, relevant regulatory updates, overseas experiences of primary review and ePI implementation, followed […]
The enhancement measures of the “1+” mechanism will come into effect on 1 May 2024. Therefore, the Regulatory Affairs Working Group jointly organized a briefing session with the Department of Pharmacology and Pharmacy, University of Hong Kong, to further enhance members’ understanding of the new pathway and relevant enhancement measures. Mr Frank Chan, Mr Lot […]
